Boothbay Fund Management LLC Has $1.57 Million Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Boothbay Fund Management LLC decreased its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 47.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 382,525 shares of the company's stock after selling 341,971 shares during the period. Boothbay Fund Management LLC owned about 0.33% of Definitive Healthcare worth $1,572,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Hennion & Walsh Asset Management Inc. lifted its position in Definitive Healthcare by 34.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company's stock valued at $209,000 after acquiring an additional 12,946 shares during the last quarter. Barclays PLC increased its stake in Definitive Healthcare by 318.8% in the 3rd quarter. Barclays PLC now owns 81,916 shares of the company's stock valued at $366,000 after purchasing an additional 62,354 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Definitive Healthcare by 431.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company's stock valued at $993,000 after acquiring an additional 180,323 shares in the last quarter. Quantbot Technologies LP raised its holdings in shares of Definitive Healthcare by 5,305.5% in the fourth quarter. Quantbot Technologies LP now owns 17,730 shares of the company's stock worth $73,000 after acquiring an additional 17,402 shares during the last quarter. Finally, 272 Capital LP lifted its stake in shares of Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company's stock valued at $4,980,000 after buying an additional 476,766 shares during the period. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Trading Up 3.3 %

DH traded up $0.09 during trading on Friday, reaching $2.84. The company had a trading volume of 369,226 shares, compared to its average volume of 856,100. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market cap of $306.61 million, a price-to-earnings ratio of -0.92, a PEG ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $7.47. The firm's 50-day simple moving average is $2.79 and its 200 day simple moving average is $3.92.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to analysts' expectations of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Equities research analysts anticipate that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on DH. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays reduced their price objective on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. Finally, The Goldman Sachs Group reduced their target price on shares of Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $5.35.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.